Neutralizing antibodies in hepatitis C virus infection: a review of immunological and clinical characteristics.
Kaplan
Mitchell
M
Department of Internal Medicine, Rush Presbyterian St. Luke's Medical Center, Rush University, Chicago, IL 60612, USA.
Gawrieh
Samer
S
Cotler
Scott J
SJ
Jensen
Donald M
DM
D000818:Animals; D002986:Clinical Trials as Topic; D003429:Cross Reactions; D006526:Hepatitis C / Q000276:immunology* / Q000628:therapy; D018937:Hepatitis C Antibodies / Q000276:immunology* / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000145:classification; D014759:Viral Envelope Proteins / Q000276:immunology; D014764:Viral Proteins / Q000737:chemistry / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
C400562:HVR1 protein, Hepatitis C virus; D018937:Hepatitis C Antibodies; D007074:Immunoglobulin G; D014759:Viral Envelope Proteins; D014764:Viral Proteins; D014765:Viral Vaccines; C091015:glycoprotein E2, Hepatitis C virus